EUVIMEDEUVIMED entdecken
Open Access

Metabolic traits shape responses to LSD1-directed therapy in glioblastoma tumor-initiating cells

Giulia Marotta iD, Daniela Osti iD, Elena Zaccheroni iD, Brunella Costanza, Stefania Faletti iD, Adriana Marinaro iD, Cristina Richichi iD, Deborah Mesa iD, Simona Rodighiero iD, Chiara Soriani iD, Enrica Migliaccio, Federica Ruscitto und 18 weitere

Science Advances · 23.05.2025 · 11 (21)

DOI: 10.1126/sciadv.adt2724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 23.05.2025. Verfasst von Giulia Marotta und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan 20139, Italy. Hauptthemen laut MEDLINE: Histone Demethylases, Glioblastoma, Neoplastic Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysine-specific histone demethylase 1A (LSD1) is an epigenetic regulator involved in various biological processes, including metabolic pathways. We demonstrated the therapeutic potential of its pharmacological inhibition in glioblastoma using DDP_38003 (LSD1i), which selectively targets tumor-initiating cells (TICs) by hampering their adaptability to stress. Through biological, metabolic, and omic approaches, we now show that LSD1i acts as an endoplasmic reticulum (ER) stressor, activating the integrated stress response and altering mitochondrial structure and function. These effects impair TICs’ oxidative metabolism and generate reactive oxygen species, further amplifying cellular stress. LSD1i also impairs TICs’ glycolytic activity, causing their metabolic decline. TICs with enhanced glycolysis benefit from LSD1-directed therapy. Conversely, metabolically silent TICs mantain ER and mitochondrial homeostasis, adapting to stress conditions, including LSD1i treatment. A dropout short hairpin RNA screening identifies postglycosylphosphatidylinositol attachment to proteins inositol deacylase 1 (PGAP1) as a mediator of resistance to LSD1i. Disruptions in ER and mitochondrial balance holds promise for improving LSD1-targeted therapy efficacy and overcoming treatment resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DemethylasesGlioblastomaNeoplastic Stem CellsHumansCell Line, TumorMitochondriaEndoplasmic Reticulum StressReactive Oxygen SpeciesAnimalsGlycolysisMice

Substanzen

Histone DemethylasesKDM1A protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan 20139, Italy.
  • Human Technopole, Viale Rita Levi-Montalcini, 1, Milan 20157, Italy.
  • Department of Oncology and Hematology-Oncology, Università degli Studi di Milano, Milan Italy.
  • Department of Physics, Politecnico di Milano, Milan, Italy.
  • CNR Institute for Photonics and Nanotechnology (CNR-IFN), Milan, Italy.
  • IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.

ORCID-Profile: Giulia Marotta, Daniela Osti, Elena Zaccheroni, Stefania Faletti, Adriana Marinaro, Cristina Richichi, Deborah Mesa, Simona Rodighiero, Chiara Soriani, Sara Sigismund, Francesco Manetti, Dario Polli, Mara-Camelia Rusu, Francesco Favero, Angela Gallo, Fabio Alfieri, Sara Gandini, Matthias J Schmitt, Gaetano Gargiulo, Roberta Noberini, Tiziana Bonaldi, Giuliana Pelicci

Zitieren

APA

Marotta, G., Osti, D., Zaccheroni, E., Costanza, B., Faletti, S., Marinaro, A., Richichi, C., Mesa, D., Rodighiero, S., Soriani, C., Migliaccio, E., Ruscitto, F., Priami, C., Sigismund, S., Manetti, F., Polli, D., Beznusenko, G. V., Rusu, M. C., Favero, F., …, & Pelicci, G. (2025). Metabolic traits shape responses to LSD1-directed therapy in glioblastoma tumor-initiating cells. Science Advances, 11(21). https://doi.org/10.1126/sciadv.adt2724

Vancouver

Marotta G, Osti D, Zaccheroni E, Costanza B, Faletti S, Marinaro A, et al. Metabolic traits shape responses to LSD1-directed therapy in glioblastoma tumor-initiating cells. Science Advances. 2025;11(21). doi:10.1126/sciadv.adt2724

BibTeX
@article{Marotta2025,
  author = {Marotta, Giulia and Osti, Daniela and Zaccheroni, Elena and Costanza, Brunella and Faletti, Stefania and Marinaro, Adriana and Richichi, Cristina and Mesa, Deborah and Rodighiero, Simona and Soriani, Chiara and Migliaccio, Enrica and Ruscitto, Federica and Priami, Chiara and Sigismund, Sara and Manetti, Francesco and Polli, Dario and Beznusenko, Galina V and Rusu, Mara-Camelia and Favero, Francesco and Corà, Davide and Silvestris, Domenico A and Gallo, Angela and Gambino, Valentina and Alfieri, Fabio and Gandini, Sara and Schmitt, Matthias J and Gargiulo, Gaetano and Noberini, Roberta and Bonaldi, Tiziana and Pelicci, Giuliana},
  title = {Metabolic traits shape responses to LSD1-directed therapy in glioblastoma tumor-initiating cells},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {21},
  doi = {10.1126/sciadv.adt2724}
}
Kostenlos starten →